Predicting Protein Pathways Associated to Tumor Heterogeneity by Correlating Spatial Lipidomics and Proteomics: The Dry Proteomic Concept
Molecular & Cellular Proteomics · 2025
DOI: 10.1016/j.mcpro.2024.100891 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular & Cellular Proteomics, 2025. Verfasst von Laurine Lagache und 4 weiteren Autor:innen. Beteiligte Einrichtung: Univ.Lille, Inserm, CHU Lille, U1192 - Proteomics Inflammatory Response Mass Spectrometry- PRISM, Lille, France. Hauptthemen laut MEDLINE: Lipidomics, Proteomics, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Prediction of proteins and associated biological pathways from lipid analyses via matrix-assisted laser desorption/ionization (MALDI) MSI is a pressing challenge. We introduced "dry proteomics," using MALDI MSI to validate spatial localization of identified optimal clusters in lipid imaging. Consistent cluster appearance across omics images suggests association with specific lipid and protein in distinct biological pathways, forming the basis of dry proteomics. The methodology was refined using rat brain tissue as a model, then applied to human glioblastoma, a highly heterogeneous cancer. Sequential tissue sections underwent omics MALDI MSI and unsupervised clustering. Spatial omics analysis facilitated lipid and protein characterization, leading to a predictive model identifying clusters in any tissue based on unique lipid signatures and predicting associated protein pathways. Application to rat brain slices revealed diverse tissue subpopulations, including successfully predicted cerebellum areas. Similarly, the methodology was applied to a dataset from a cohort of 50 glioblastoma patients, reused from a previous study. However, among the 50 patients, only 13 lipid signatures from MALDI MSI data were available, allowing for the identification of lipid-protein associations that correlated with patient prognosis. For cases lacking lipid imaging data, a classification model based on protein data was developed from dry proteomic results to effectively categorize the remaining cohort.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Univ.Lille, Inserm, CHU Lille, U1192 - Proteomics Inflammatory Response Mass Spectrometry- PRISM, Lille, France.
- Univ.Lille, Inserm, CHU Lille, U1192 - Proteomics Inflammatory Response Mass Spectrometry- PRISM, Lille, France; Department of Neurosurgery and Neurology, Clinical Neuroscience Center, University Hospital Zurich and Uni…
- Univ.Lille, Inserm, CHU Lille, U1192 - Proteomics Inflammatory Response Mass Spectrometry- PRISM, Lille, France; Department Institut Universitaire de France, Ministère de l'Enseignement supérieur, de la Recherche et de…
Zitieren
APA
Lagache, L., Zirem, Y., Le Rhun, É., Fournier, I., & Salzet, M. (2025). Predicting Protein Pathways Associated to Tumor Heterogeneity by Correlating Spatial Lipidomics and Proteomics: The Dry Proteomic Concept. Molecular & Cellular Proteomics. https://doi.org/10.1016/j.mcpro.2024.100891
Vancouver
Lagache L, Zirem Y, Le Rhun É, Fournier I, Salzet M. Predicting Protein Pathways Associated to Tumor Heterogeneity by Correlating Spatial Lipidomics and Proteomics: The Dry Proteomic Concept. Molecular & Cellular Proteomics. 2025. doi:10.1016/j.mcpro.2024.100891
BibTeX
@article{Lagache2025,
author = {Lagache, Laurine and Zirem, Yanis and Le Rhun, Émilie and Fournier, Isabelle and Salzet, Michel},
title = {Predicting Protein Pathways Associated to Tumor Heterogeneity by Correlating Spatial Lipidomics and Proteomics: The Dry Proteomic Concept},
journal = {Molecular & Cellular Proteomics},
year = {2025},
doi = {10.1016/j.mcpro.2024.100891}
}
EUVIMED